• Leads a high performing Respiratory Product Strategy Team (RPST) comprised of cross-functional leaders accountable for setting the strategy for the late stage respiratory programs • Direct management and development of medical monitors and clinical scientists • Develops high quality, ambitious development plans for asthma and COPD programs, aligned with late-stage and corporate objectives and compliant with all relevant regulations • Recruits, mentors and manages late-state clinicians and scientists • Collaborates with Head of Safety and PV to define risk-benefit profiles • Collaborates with Clinical operations and CRO to deliver study to timelines and budget • Oversees protocol development and clinical/scientific content for regulatory submissions and interactions • Provides medical leadership and awareness of evolving external landscape for late-stage clinical trials in respiratory diseases (asthma, COPD) • Drives development and refinement of Target Product Profiles (TPPs), Target Product Claims, and clinical development strategies • Oversee protocol development, study design, medical review of data, and safety monitoring • Serve as the primary medical contact for clinical sites, investigators, and regulatory bodies • Guide interactions with external stakeholders including KOLs, advisory boards, and CROs • Represent Generate externally at scientific, medical, and regulatory meetings